Skip to content

Interlaminar epidural platelet rich plasma versus epidural steroid injection for herpes zoster neuralgia: a randomized controlled trial

Interlaminar epidural platelet rich plasma versus epidural steroid injection for herpes zoster neuralgia: a randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053300
Enrollment
Unknown
Registered
2021-11-18
Start date
2021-11-30
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

ESI(epidural steroid injection) group :Epidural injection of compound betamethasone
EPRP(epidural platelet rich plasma injection) group:Epidural injection of platelet rich plasma

Sponsors

Hong Kong University-Shen Zhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 60 years; 2. NRS pain score > 3 over the week; 3. Onset of herpes zoster within 1 month; 4. Able to provide informed consent; 5. Thoracolumbar herpes zoster.

Exclusion criteria

Exclusion criteria: 1. Patients requiring surgical intervention; 2. Bilateral involvement of herpes zoster; 3. Coagulopathy (platelet count less than 100,000/mL, international normalized ratio [INR] over 1.5); 4. Using anticoagulant and/or antiplatelet medication; 5. Received epidural steroid injection within the past 1 year; 6. Systemic infection; 7. Allergic to contrast dye, steroids, PRP, local anaesthetic; 8. Pregnancy; 9. Physically unable to tolerate epidural injection; 10. Uncontrolled psychiatric disorder; 11. Active or a history of substance use disorder (including alcohol opioid); 12. Known serious disorder of immunity (e.g. AIDS); 13. Those receiving systemic steroid therapy; 14. Heavy skin eruption (no suitable skin area for needle injection); 15. Those who received spinal surgery or had severe spinal malformation.

Design outcomes

Primary

MeasureTime frame
Pain score;Percentage of pain relieve;

Secondary

MeasureTime frame
SF-36(short form 36 questionnaire);Psychological assessment;

Countries

China

Contacts

Public ContactLi Xuanying

Hong Kong University-Shen Zhen Hospital

lixy0@hku-szh.org+86 18682413026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026